Purpose: Severely obese patients are being encountered more frequently in clinical practice. Factors implicated in the relationship between obesity and cardiovascular disease may be measured from a blood sample obtained through arterial access in a cardiology setting, such as during cardiac catheterization or heart surgery. e comparability of a given sample site (arterial vs. venous) with regards to blood parameters is yet to be established.
e prevalence of obesity has increased over the last two decades and, alarmingly, a dramatic rise in the severe classes of obesity has been reported [1, 2] . Severe obesity is associated with a cluster of comorbidities, a ecting many systems of the body, including the cardiovascular system. erefore, the severely obese patients are becoming a signi cant population in the eld of cardiology. In the search to understand the pathophysiological mechanisms of obesity, there is a growing interest regarding neural, metabolic and endocrine peripheral signals that may regulate appetite and body weight. Molecules involved in this peripheral signaling are derived from either adipose tissue, including leptin and adiponectin, or from the gastrointestinal tract, such as ghrelin, and are released into the blood stream. Concentrations of these hormones may be in uenced by insulin and glucose [3] as well as by non-esteri ed fatty acids (NEFA) [4] , and may be modulated by in ammatory factors such as high sensitive C reactive protein (hs-CRP) [5] . e strong association between obesity and cardiovascular disease is of considerable interest [6] . Growing evidence suggests that leptin, adiponectin and ghrelin may be speci cally implicated in the relationship between obesity and cardiovascular disease and that these signalling molecules may have an impact on amino-terminal pro-brain natriuretic peptide (NT-proBNP) levels [7] . Further studies are needed to explore their roles [8] [9] [10] [11] [12] .
In the clinical setting, drawing blood samples from severely obese patients, in order to assess the circulating concentration of these molecules, may be di cult. Since many of these patients undergo invasive interventions, such as percutaneous transluminal coronary angioplasty (PTCA), cardiologists have access to an arterial line, facilitating blood sampling; however, most publications adressing leptin, adiponectin and ghrelin levels report results from blood obtained from venous sources [8, 9, 11] . e impact of the sampling site on the values of various laboratory analyses has been repeatedly debated [13] [14] [15] .
us, the purpose of this study was to compare the circulating concentrations of leptin, adiponectin, total ghrelin, glucose, insulin, NEFA, NT-proBNP, and hs-CRP obtained in a clinical context where there is the potential for blood samples to be collected from arterial or venous sites.
Methods
Randomly selected men and women, 18 years of age or older, with an indication for bariatric surgery (BMI ≥ 40 kg/m 2 or BMI ≥ 35 kg/m 2 with associated comorbidities) were invited to participate in this study. Subjects who had previously undergone bariatric surgery or those bearing a pacemaker were excluded (as per manufacturer's safety indication, a patient with a pacemaker cannot undergo electrical bioimpedance assessment for adiposity measurement). e experimental protocol was approved by the ethics committee of the and all patients gave their written informed consent.
Height was measured using a stadiometer (SECA, 216 1814009, Brooklyn, NY, USA). Total body mass, body mass index (BMI), lean and fat masses were evaluated with an electrical bioimpedance balance (Tanita TBF-310, Tokyo, Japan) following a 12 hour fast.
In preparation for bariatric surgery, the anaesthesiologist installed an arterial catheter in the radial artery and a central venous catheter in either the jugular or the subclavian vein, depending on the accessibility. A 12-15 cm long catheter was inserted into the superior vena cava, close to the heart's right atrium, for venous samples. Shortly a er induction, but before beginning the surgical procedure, blood was simultaneously withdrawn from both line accesses (arterial and venous) in two syringes and immediately transferred into 6 mL tubes containing K2EDTA. Tubes were rapidly placed on ice until centrifugation. Samples were centrifuged for 15 minutes at 3500 rpm, at 4ºC within 15 minutes following collection. e separated plasma was collected and frozen in 2 mL aliquots at -80ºC until analysis.
Concentrations of glucose and NEFA were measured using colorimetric enzymatic assays from Wako (Richmond, VA, USA). Insulin, adiponectin, leptin and total ghrelin concentrations were measured using radioimmunological assays according to manufacturer's protocol (Millipore, MA, USA). High sensitive C-reactive protein (hs-CRP) levels were measured using a commercially available ELISA according to manufacturer's protocol (Millipore, MA, USA). NT-proBNP concentrations were analyzed with a Modular system from Roche Diagnostics, using Roche reactants (Roche Diagnostics, IN, USA).
Data are presented as the arithmetic mean ± standard deviation. Comparisons between arterial and venous concentrations of designated molecules were analysed using the Student's paired t-test. A Wilcoxon Signed Rank test was performed when normality test failed. A p value <0.05 was considered statistically signi cant. Data were analysed using the statistical packages Sigma Stat 3.0 (Chicago, IL, USA). Table 1 presents the anthropometric characteristics of the fteen severely obese patients recruited in our study: 4 men and 11 women. Mean age was 40 ± 10 years. Weight of the subjects was 131.8 ± 21.7 kg with a BMI of 50.2 ± 6.7 kg/m 2 . Average fat free mass was 63.4 ± 9.6 kg and fat mass was 68.3 ± 16.7 kg, representing 51.5 ± 6.1 % of the total body mass. Table 2 presents the arterial (A) and venous (V) blood concentrations of leptin, total ghrelin, adiponectin, insulin, glucose, NEFA, hs-CRP and NT-proBNP. No statistically signi cant di erences were observed between arterial and venous blood concentrations for any of these molecules (all p values >0.1). As an example, Figure 1 shows arterial and venous concentrations of glucose. While there were slight individual variations between arterial and venous samples, there was no statistical difference between collection sites (p=0.362).
Results

Discussion
In a group of severely obese patients undergoing bariatric surgery, circulating concentrations of leptin, total ghrelin, adiponectin, insulin, glucose, NEFA, NT-proBNP, and hs-CRP concentrations in blood taken from the radial artery compared to blood taken from the superior vena cava were comparable and clinically acceptable.
e impact of collection site on blood concentrations of various molecules have been questioned in previous studies. Neptun et al. [16] reported that, in rats, the sampling site and collection method may be a major source of variation in clinical chemistry measurements, including those of glucose, cholesterol, triglycerides, ions and others. In canines, complete blood count obtained from venous and arterial blood samples were not comparable, yet values for haemostatic parameters with the exception of brinogen and thrombin time were similar [17] . In humans, it was also reported that in venous blood, there was a signi cant increase in erythrocyte count (2.7%) and haematocrit (3.1%) compared to arterial blood [18] . Furthermore, arterial and venous lactate levels showed discrepancies [13, 19] .
us, depending on a given parameter, the impact of sampling site may be important.
It is important to note that both sampling sites in this study represent general circulating levels and not tissue-speci c levels. Most studies reporting arteriovenous di erences in the levels of the molecules in this study were conducted for the purpose of measuring production or excretion by a speci c organ. is is the case for many studies regarding glucose [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , insulin [30] [31] [32] , NEFA [22] , leptin [33] [34] [35] and NT-ProBNP levels [36] . Consequently, the results of these studies may not be comparable to our results because of di erent experimental designs.
To our knowledge, Evron et al. [13] is the only group who used a study design similar to the one reported here. In a cohort of 100 patients undergoing orthopaedic or colon surgery, blood was simultaneously sampled from three sites: 1) peripheral vein, 2) central vein and 3) radial artery a er induction of anaesthesia. Concentrations of hemoglobin, electrolytes, pH, blood gases, lactate and glucose were measured and no statistically signi cant di erences were found, with the exception of lactate. While studies on arteriovenous di erences used di erent protocols, a few studies used peripheral sites bringing some information relevant to our study. Fontana et al. [30] reported arteriovenous concentration di erences for insulin in the portal vein vs. peripheral artery blood in 25 severely obese subjects undergoing gastric bypass surgery. Fasting plasma insulin concentration in the portal vein was more than twice that in the peripheral artery (34.4 ± 21 and 15.2 ± 8 μU/mL respectively). Similar observations were also reported by Horwitz et al. [37] , who observed higher insulin concentrations in the portal vein compared with an antecubital vein in six non-diabetic subjects. It is important to note that insulin is extracted by the liver. Our results regarding insulin concentrations (A: 17.93 ± 9.70 and V: 18.57 ± 10.46 μU/mL) are comparable to those of Fontana et al. [30] measured in a peripheral artery (15.2 ± 8 μU/mL) in a similar population. Venous and arterial insulin concentrations have never been compared. e results reported here complement published data since central venous and peripheral arterial insulin levels were within the same range.
In this study, venous blood was collected from the superior vena cava, which primarily drains the brain and the brachial adipose tissue and muscle. Esler et al. [35] reported that there was no detectable net ux of leptin through the forearm, results that have also been supported by Henriksen et al. [33] who found that in normal subjects there is a signi cant spillover of leptin into the iliac vein but not in the cubital vein. Esler et al. [35] also reported that leptin levels were higher in the internal jugular vein than the arterial value, suggesting a production of leptin by the brain in 15 lean to obese men (BMI range 19.6-38.5 kg/m 2 ). In contrast, no signi cant di erences in leptin levels were observed in this severely obese population.
e lack of details on the speci c arterial sampling site and on the study population in the publication of Esler et al. [35] renders it di cult to reconcile their results with ours. Arteriovenous di erences in ghrelin concentrations were also reported by Moller et al. [38] in 22 lean subjects (BMI of 23.6 ± 0.6 kg/ m 2 ). Femoral artery concentration was 0.960 ± 0.082 ng/mL, while hepatic vein level was 1.102 ± 0.090 ng/mL, a 15% difference suggesting that the splanchnic bed is a major source of ghrelin 38 . Although the population in this study was severely obese, the concentrations of total ghrelin from the venous (0.76 ± 0.35 ng/mL) and the arterial (0.86 ± 0.27 ng/mL) sites were comparable to the artery site results reported by Moller et al. [38] . In support of our data, Goodyear et al. [39] recently reported no signi cant di erences between central venous, arterial and peripheral venous sampling sites for either acylated ghrelin, des-acyl ghrelin or total ghrelin concentrations in humans. In their study of severely obese subjects, Fontana et al. [30] reported no signi cant di erence in circulating levels of adiponectin between blood sampled from the portal vein and the radial artery. Consistent with these data, no statistically signi cant di erence was seen here between venous and arterial adiponectin levels. Although Palsgaard-Van Lue et al. [17] found no statistical di erence in hs-CRP values in arterial and venous blood samples in canines, no previous data have yet been reported in humans.
We acknowledge that this study included a small number of speci cally selected severely obese patients and therefore our results may not be applicable to other population. Although it is clear that there is inevitable inter-individual variability in the parameters measured, it is of importance to emphasize that each patient of our study was his/her own control, thereby reducing intra-individual variability.
Conclusion
e collection site, namely radial artery and superior vena cava, does not signi cantly in uence clinical concentrations of leptin, total ghrelin, adiponectin, insulin, glucose, NEFA, hs-CRP and NT-proBNP in a group of severely obese patients. Our results suggest that for severely obese patients, for whom it is di cult to obtain antecubital venous blood samples or for whom arterial access would be more convenient (such as during PTCA or surgery), blood samples may be withdrawn from either radial artery or superior vena cava for the measurement of leptin, total ghrelin, adiponectin, insulin, glucose, NEFA, hs-CRP and NT-proBNP levels.
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